109 related articles for article (PubMed ID: 23579486)
1. Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.
Katiyar P; Ma Y; Riegel A; Fan S; Rosen EM
Mol Endocrinol; 2009 Aug; 23(8):1135-46. PubMed ID: 19389812
[TBL] [Abstract][Full Text] [Related]
2. Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.
Richardson TI; Clarke CA; Yu KL; Yee YK; Bleisch TJ; Lopez JE; Jones SA; Hughes NE; Muehl BS; Lugar CW; Moore TL; Shetler PK; Zink RW; Osborne JJ; Montrose-Rafizadeh C; Patel N; Geiser AG; Galvin RJ; Dodge JA
ACS Med Chem Lett; 2011 Feb; 2(2):148-53. PubMed ID: 24900294
[TBL] [Abstract][Full Text] [Related]
3. The Chemistry and Biology of Nakiterpiosin - C-nor-D-Homosteroids.
Gao S; Wang Q; Wang G; Lomenick B; Liu J; Fan CW; Deng LW; Huang J; Lum L; Chen C
Synlett; 2012 Oct; 16(23):2298-2310. PubMed ID: 23226922
[TBL] [Abstract][Full Text] [Related]
4. Effect of 17β-Estradiol, Progesterone, and Tamoxifen on Neurons Infected with
Galván Ramírez ML; Dueñas-Jiménez JM; Gutiérrez-Maldonado AF; Rodríguez Pérez LR
Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683495
[No Abstract] [Full Text] [Related]
5. Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics.
Zheng L; Lin VC; Mu Y
PLoS One; 2016; 11(11):e0165824. PubMed ID: 27824891
[TBL] [Abstract][Full Text] [Related]
6. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
7. Tracking progesterone receptor-mediated actions in breast cancer.
Knutson TP; Lange CA
Pharmacol Ther; 2014 Apr; 142(1):114-25. PubMed ID: 24291072
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in structure of progestins and their binding to progesterone receptors.
Cabeza M; Heuze Y; Sánchez A; Garrido M; Bratoeff E
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):152-9. PubMed ID: 24666307
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors.
Takimoto GS; Graham JD; Jackson TA; Tung L; Powell RL; Horwitz LD; Horwitz KB
J Steroid Biochem Mol Biol; 1999; 69(1-6):45-50. PubMed ID: 10418980
[TBL] [Abstract][Full Text] [Related]
10. A new strategy for selective targeting of progesterone receptor with passive antagonists.
Khan JA; Tikad A; Fay M; Hamze A; Fagart J; Chabbert-Buffet N; Meduri G; Amazit L; Brion JD; Alami M; Lombès M; Loosfelt H; Rafestin-Oblin ME
Mol Endocrinol; 2013 Jun; 27(6):909-24. PubMed ID: 23579486
[TBL] [Abstract][Full Text] [Related]
11. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
[TBL] [Abstract][Full Text] [Related]
12. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.
Esber N; Cherbonnier C; Resche-Rigon M; Hamze A; Alami M; Fagart J; Loosfelt H; Lombès M; Chabbert-Buffet N
Horm Cancer; 2016 Apr; 7(2):137-47. PubMed ID: 26941094
[TBL] [Abstract][Full Text] [Related]
14. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
